Costco Wholesale (COST) 2025 Update / Briefing June 04, 2025 04:00 PM ET Speaker0 Hello. I'm Andrew Yoon, director of finance and investor relations, and I'll review our sales results for the four week retail month of May, which started on Monday, May 5, and ended Sunday, June 1. This period is compared to the four weeks that began last year on Monday, May 6, and ended Sunday, June 2. This call will include forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 ...

Lexeo Therapeutics (LXEO) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Hello, everyone. Good afternoon, and welcome to the Jefferies Global Healthcare Conference. My name is Ella Rosenblatt, and I'm with the Jefferies investment banking team, and it is my pleasure to introduce Nolan Townsend and Eric from Lexio Therapeutics. Speaker1 Alright. Thank you for having us. It's, great to be here and, spend some time talking about the Lexio story. So, you know, to start, Lexio is a gene therapy company focus ...

Tandem Diabetes Care (TNDM) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 So thanks a lot for joining us for this session here with Tandem Diabetes. We have Lee Vosler, the CFO, and Katie from Investor Relations. We're going to have about a half hour for moderated Q and A. Lee, I wanted to just kick things off with a good old high level question. So maybe we could just talk a little bit about how Tandem's evolving because you have gone from being a tube pump maker to one that's now integrating with a l ...

Bio-Techne (TECH) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Let's get started. I'm Tycho Peterson from the life science team. It's my pleasure to introduce Biotechni. Maybe just to, kick it off, we can start with a little state of the union. And obviously, a lot of volatility around the macro. We we were just talking on US, you know, NIH academic funding. Maybe just talk a little bit about that, talk about pharma dynamics, and then the evolving situation in China. Speaker1 Yeah, sure. Well, first o ...

4D Molecular Therapeutics (FDMT) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 All right. Welcome, everybody. Thank you. It's a pleasure to be here. I'm Dave Kern, co founder and CEO of four d Molecular Therapeutix, or four d MT. Welcome. Okay. We'll be giving some brief introductory remarks with a brief slide deck here today and then get into Q and A. 4,150 is our lead product for wet AMD and DME. Key updates here is the Forefront I Phase III trial is underway and enrolling briskly, which is very exci ...

Tarsus Pharmaceuticals (TARS) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Hey, good afternoon. Welcome to day one of the Jefferies Healthcare Conference. My name is Dennis Ding, biotech analyst at Jefferies. I have the great pleasure of having CFO Jeff Farrow and CMO Aziz Mottawala here from Tarsus Pharmaceuticals. Welcome. Why don't we kick things off by just giving a brief background around the company as it stands today and some of the progress that the company has made over the last one or two ye ...

Nurix Therapeutics (NRIX) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Rutideg, which we call bexdeg for short, being a degrader. We've got an important new suffix on there to indicate it's a degrader. So, I'll be calling it bexdeg n x five nine four eight. Speaker1 Okay. Bexdeg. Speaker0 Yeah, bexdeg. Speaker1 Yeah, awesome. So, maybe just to clarify, this EHA update will be focused on the phase 1a, more mature data, but not from the phase 1b expansion cohort for CLL. Speaker0 Right. It'll be on the ...

Enliven Therapeutics (ELVN) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 It's your Speaker1 day. Just grinding through this. Speaker0 It's fine. Yeah. It's gonna run around. It's like a barn. But it's good though. All set? Yeah. Okay. Hi, everyone. My name is Maury Raycroft and one of the biotech analysts at Jefferies. I'm happy to introduce Sam Kintz, the CEO of Enliven Therapeutics. Thanks for joining us today, Sam. And we're gonna do fireside chat format. So maybe for those who are new to the story ...

Inotiv (NOTV) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Okay. Okay. Alright. Hi. Good afternoon. I'm Dave Windley with Jefferies Healthcare Equity Research, CRO coverage. Thanks so much for attending or listening to our twenty twenty five Healthcare Conference here in New York. Our next presenting company is Innative. NOTV is the ticker and the company's CEO is here with us. Bob Leisure, Beth Taylor here in front of me in the audience. The company's CFO is also along with. So Bob, we just said this ...

Scholar Rock Holding (SRRK) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 Fantastic. All right. Well, thank you. Good afternoon everyone. Welcome to the next session here at the Jefferies Healthcare Conference. I'm Michael Yee, a senior biotechnology analyst, and really happy to have a couple members of the ScholarRock management team with us. And importantly, this somewhat of a new team that got introduced over the last month. So I'd love perhaps, although David, you were chairman, an opportunity for ...